Position in SVTR
Snapshot 2026-11-05- Startup SignalsTop 50%↓36
- Life SciencesTop 50%↓3
- Healthcare ServicesTop 50%–
- BCI#7of 20↓1
About
Gestalt Technology, founded in 2026 in Chengdu, develops and applies ultrasound-based brain-computer interface technology.
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Funding history
- 2026-07-03Angel+$59M
Investors · C Capital, Lens Technology, Dalton Venture, Gobi Partners, Meridian Capital, 临港科创投, 中电健康基金, 复容投资, HongShan, 国泰创投, 清松资本, Sinovation Ventures, Seas CapitalSource · news.pedaily.cn ↗
- 2026-03Angel$21M
Investors · Fourier Intelligence, 国生资本, 清松资本, Gobi Partners, Dalton VentureSource · SVTR Weekly #148 ↗
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- 格式塔科技
Ultrasound brain-computer interface for whole-brain read/write, treating chronic pain, stroke rehabilitation, PTSD and other neurological conditions
Angel · $80M · 2026-07
$80M
United States
BusinessLatest roundTotal raisedDate- Blackrock Neurotech
Develops brain-computer interface technology designed to help patients with paralysis or other neurological conditions control digital devices and reg…
Undisclosed · $200M · 2024-05
$200M - Axoft
Implantable brain-computer interfaces using biomimetic materials…
Series A · $60M · 2026-05
$60M - Nudge
Founded by Coinbase Co-founder Fred Ehrsam; develops non-invasive brain-computer interface devices
Series A · $100M · 2025-07
$100M
China
BusinessLatest roundTotal raisedDate- BCI-Sonics
Non-invasive AI ultrasound brain-computer interface (transcranial focused ultrasound neuromodulation + multimodal brain reading and AI neural decoding…
Series A · $42M · 2026-09
$42M - StairMed
Developer of implantable brain-computer interface systems
Strategic · $153M · 2026-03
$153M - 智冉医疗
Next-generation flexible brain-computer interface platform (invasive)
Series A · $83M · 2026-02
$83M
Europe
BusinessLatest roundTotal raisedDate- InBrain Neuroelectronics
Graphene-based brain-computer interface technology for neurological disorders such as Parkinson's disease.
Series B · $50M · 2024-11
$50M - Neurosoft Bioelectronics
Flexible, stretchable, non-penetrating brain-computer interfaces and neural electrodes to record/stimulate brain-surface activity
Seed · $20M · 2026-05
$20M - Tucuvi
Voice AI that automates clinical follow-up and care management workflows
Series A · $184M · 2026-01
$184M
Other / unspecified
BusinessLatest roundTotal raisedDate- 脑思科技
Brain-computer interface electrodes and neural decoding systems
Angel · $10M · 2026-05
$10M - Even Healthcare
Health subscription membership for individuals and businesses (unlimited consultations, free testing)…
Series B · $120M · 2026-10 · Valuation $300M
$120MValuation $300M - Brain.space
Non-invasive brain monitoring platform with real-time neural data analysis
Series A · $11M · 2025-03
$11M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
Dimension Capital
10 Life Sciences deals in the last 24 months · 4 at a nearby stage · 1 in Southwest China
Request intro →OrbiMed Advisors
9 Life Sciences deals in the last 24 months · 3 at a nearby stage · 4 in Southwest China
Request intro →Qiming Venture Partners
9 Life Sciences deals in the last 24 months · 3 at a nearby stage · 7 in Southwest China
Request intro →Lilly Asia Ventures
8 Life Sciences deals in the last 24 months · 2 at a nearby stage · 7 in Southwest China
Request intro →Matrix Partners China
6 Life Sciences deals in the last 24 months · 4 at a nearby stage · 4 in Southwest China
Request intro →Legend Capital
5 Life Sciences deals in the last 24 months · 3 at a nearby stage · 4 in Southwest China
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.